摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2,6-dichloro-4-((methylamino)methyl)phenyl)-N-(6-methylpyrimidin-4-yl)-3H-imidazo[4,5-c]pyridin-4-amine | 1334409-87-8

中文名称
——
中文别名
——
英文名称
2-(2,6-dichloro-4-((methylamino)methyl)phenyl)-N-(6-methylpyrimidin-4-yl)-3H-imidazo[4,5-c]pyridin-4-amine
英文别名
2-[2,6-dichloro-4-(methylaminomethyl)phenyl]-N-(6-methylpyrimidin-4-yl)-1H-imidazo[4,5-c]pyridin-4-amine
2-(2,6-dichloro-4-((methylamino)methyl)phenyl)-N-(6-methylpyrimidin-4-yl)-3H-imidazo[4,5-c]pyridin-4-amine化学式
CAS
1334409-87-8
化学式
C19H17Cl2N7
mdl
——
分子量
414.297
InChiKey
GGNWHPNOHWRKBJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    91.4
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • [EN] COMPOUNDS AND METHODS OF TREATING CANCERS<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE CANCERS
    申请人:CULLGEN SHANGHAI INC
    公开号:WO2020200291A1
    公开(公告)日:2020-10-08
    This disclosure relates to heterobifunctional compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the heterobifunctional compounds, and to methods of use the heterobifunctional compounds for the treatment of certain disease in a subject in need thereof. The disclosure also relates to methods for identifying such heterobifunctional compounds.
    这份披露涉及异双功能化合物(例如,双功能小分子化合物),包括一种或多种异双功能化合物的组合物,以及使用这些异双功能化合物治疗患有特定疾病的需要该类治疗的受试者的方法。该披露还涉及识别此类异双功能化合物的方法。
  • IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
    申请人:Lai Yingjie
    公开号:US20130096104A1
    公开(公告)日:2013-04-18
    The invention provides compounds of Formulas Ia-Ib, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R 1 , R 2 , R 4 , R 5 and R 16 are defined herein, a pharmaceutical composition that includes a compound of Formulas Ia-Ib and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy, as an inhibitor of TYK2 kinase and conditions related, such as inflammatory illnesses, inflammatory bowel disease or psoriasis.
    本发明提供了公式Ia-Ib的化合物、立体异构体或其药学上可接受的盐,其中A、X、R1、R2、R4、R5和R16在此定义,一种包括公式Ia-Ib化合物和药学上可接受的载体、佐剂或车载物的药物组合物,以及使用该化合物或组合物作为TYK2激酶的抑制剂和相关疾病的治疗方法,例如炎症性疾病、炎症性肠病或牛皮癣。
  • [EN] COMPOUNDS AND METHODS OF TREATING DISEASES<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE MALADIES
    申请人:CULLGEN SHANGHAI INC
    公开号:WO2022068933A1
    公开(公告)日:2022-04-07
    Provided are heterobifunctional compounds (e.g., bi-functional small molecule compounds), compositions comprising one or more of the heterobifunctional compounds, methods of use the heterobifunctional compounds for the treatment of certain disease in a subject in need thereof, and methods for identifying such heterobifunctional compounds.
    提供了异双功能化合物(例如,双功能小分子化合物),包含一种或多种异双功能化合物的组合物,使用异双功能化合物治疗患有某些疾病的需要的受试者的方法,以及鉴定此类异双功能化合物的方法。
  • [EN] IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS D'IMIDAZOPYRIDINE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
    申请人:HOFFMANN LA ROCHE
    公开号:WO2011113802A2
    公开(公告)日:2011-09-22
    The invention provides compounds of Formulas Ia-Ib, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4, R5 and R16 are defined herein, a pharmaceutical composition that includes a compound of Formulas Ia-Ib and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy.
查看更多